The prevention and treatment for reactivation of hepatitis B in immunosuppression
- VernacularTitle:免疫抑制状态乙型肝炎病毒的再激活及防治
- Author:
Lingyan FAN
;
Zhi ZHOU
- Publication Type:Journal Article
- Keywords:
hepatitis B virus;
immunosuppression;
HBV reactivation;
nucleosides
- From:
Chinese Journal of Practical Internal Medicine
2003;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
Hepatitis B virus(HBV)will become reactive in non-active HBsAg carriers when they are in the immunosuppression status,which is often caused by cytotoxic drugs in chemotherapy or immunosuppressants.Liver damage will be induced in such patients and even liver failure in some patients.Nucleoside analogues could be used in early phase as prophylaxis for reactivation of hepatitis B in immunosuppression and to improve clinical prognosis.
